18 38

Cited 0 times in

First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET

Authors
 D. Hong  ;  L. Bazhenova  ;  B.C. Cho  ;  S. Sen  ;  M. Ponz-Sarvise  ;  R. Heist  ;  Z. Zimmerman  ;  X. Le  ;  D. Xuan  ;  Z. Junming  ;  J. Lee 
Citation
 EUROPEAN JOURNAL OF CANCER, Vol.138 : S1, 2020-10 
Journal Title
EUROPEAN JOURNAL OF CANCER
ISSN
 0959-8049 
Issue Date
2020-10
Files in This Item:
T999202168.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Byoung Chul(조병철) ORCID logo https://orcid.org/0000-0002-5562-270X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184929
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links